94 related articles for article (PubMed ID: 2785598)
1. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
[TBL] [Abstract][Full Text] [Related]
2. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
3. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
4. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
Hirschl M; Kundi M
J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
[TBL] [Abstract][Full Text] [Related]
5. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
7. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
9. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.
Groen H; Wichers G; ter Borg EJ; van der Mark TW; Wouda AA; Kallenberg CG
Am J Med; 1990 Jul; 89(1):34-41. PubMed ID: 2368791
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
Houtman PM; Kallenberg CG; Fidler V; Wouda AA
J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
Wollersheim H; Thien T
Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
[TBL] [Abstract][Full Text] [Related]
15. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
Yunus MB; Hussey FX; Aldag JC
J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
[TBL] [Abstract][Full Text] [Related]
16. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
[TBL] [Abstract][Full Text] [Related]
17. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
[TBL] [Abstract][Full Text] [Related]
18. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
19. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.
Kallenberg CG; Vellenga E; Wouda AA; The TH
J Rheumatol; 1982; 9(6):878-84. PubMed ID: 7161779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]